Vision

• Cytovac conducts research with the aim to develop immuno-therapeutic methods for curing cancer diseases.
• Cytovac develops new efficacious autologous cell-based cancer therapy methods with few side effects compared to conventional standard of care cancer therapies.
• Cytovac aims to secure financial funding for developing products for diseases with unmet needs.
• Cytovac’s ALECSAT platform is open for entering partnership agreements, both with academic and private institutions.

• Cytovac and the employees of the company, strive to maintain a high ethical level for all activities.
• Cytovac should be an attractive workplace for employees wishing to be a part of research and development at a high international level.
• Cytovac protects its scientific innovation through patenting.